PLUR PLURI INC

-

PLURI INC Reported Earnings

Thursday, May 14, 2026 · 12:00 AM ET

PLURI INC (PLUR) reported a loss of $0.55 per share on revenue of $0.17 million for the . . Revenue fell 60.89% compared to the same quarter a year ago.

Pluri Inc. is a biotechnology company. Its technology platform, a patented and validated state-of-the-art 3D cell expansion system, advances novel cell-based solutions for a range of medicine and climate change to food scarcity, animal cruelty and beyond. Pluri Inc., formerly known as Pluristem Therapeutics Inc., is based in HAIFA, Israel.

Earnings Whisper Grade
Power Rating
Reported Earnings
($0.55)
Earnings Whisper®
Consensus Estimate
Earnings Surprise
Earnings Growth41.5 %
Reported Revenue
$0.17M
Revenue Estimate
Revenue Surprise
Revenue Growth-60.9 %